Operating cash flow remains erratic, peaking at $9.5 billion in 2025Q3, reflecting the unpredictable timing of premium inflows and claims outflows associated with legacy insurance liabilities.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 |
|---|
| Cash from Operations | 28.96B | 32.08B | 26.49B | 20.42B | 16.63B | 23.16B | 20.05B | 20.54B | 19.19B | 17.79B | 17.04B | 10.33B | 10.81B | 9.71B | 11.08B | 10.87B | 11.56B | 12.02B | 7.92B | 7.16B | 6.68B | 7.4B | 5.75B | 2.65B | 2.26B | -2.73B | 1.91B | 2.91B | -10.91M |
| Operating CF Growth % | 0.53% | 21.08% | 29.73% | 22.82% | -28.19% | 15.5% | -2.4% | 7.06% | 7.85% | 4.43% | 64.85% | -4.37% | 11.31% | -12.38% | 1.95% | -5.98% | -3.85% | 51.75% | 10.64% | 7.23% | -9.75% | 28.59% | 116.69% | 17.58% | 182.65% | -242.77% | -34.2% | 26767.85% | - |
| Operating CF / Revenue % | 36.49% | 60.51% | -363.53% | -290.22% | 68.83% | 38.69% | 26% | 26.4% | 51.49% | 31.41% | 32.96% | 31.49% | 20.36% | 55.52% | 39.46% | 21.74% | 30.73% | 29.97% | 24% | 20.12% | 19.53% | 22.63% | 21.33% | 16.09% | 13.66% | -16.83% | 13.52% | 20.61% | -0.1% |
| Net Income | 6.42B | 5.57B | 5.88B | 5.1B | -1.98B | 6.91B | 5.58B | 5.5B | 4.89B | 2.26B | 3.13B | 2.29B | 3.59B | 3.17B | 1.69B | 245M | -1.53B | 1.42B | 497M | 4.23B | 3.97B | 3.29B | 2.56B | 1.54B | 1.37B | 1.17B | 1.07B | 868.77M | 704.54M |
| Depreciation & Amortization | -412.54M | 876.29M | -1.51B | 581M | -1.47B | 529M | 656M | 626M | 747M | 560M | 693M | 580M | 462M | 426M | 390M | 345M | 316M | 304M | 283M | 281M | 234M | -749M | -675M | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 2M | 5M | 9M | 14M | 11M | 10M | 15M | 19M | 16M | 14M | 15M | 17M | 23M | 25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 48M | 0 | 311M | 470M | -1.99B | -127M | 280M | -454M | 930M | -331M | -235M | -343M | 98M | 475M | -1.5B | -210M | -456M | -1.27B | -237M | 928M | 996M | 720.75M | 632.62M | 202.88M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6.79B | -8.69B | -1.08B | -4.48B | 10.99B | 5B | -22.37B | -20.15B | 9.1B | -6.96B | -2.73B | 1.55B | -17.31B | 17.3B | -2.03B | -14.53B | -2.06B | 11.44B | 4.18B | -218.34M | -2.26B | -1.23B | 3.29B | 529.25M | 883.57M | -3.9B | 844.13M | 2.04B | -715.44M |
| Working Capital Changes | 29.62B | 34.33B | 22.89B | 18.75B | 11.08B | 10.83B | 35.89B | 35.01B | 3.52B | 22.24B | 16.15B | 6.24B | 23.95B | -11.68B | 12.52B | 25B | 15.26B | 134M | 3.19B | 1.94B | 3.74B | 5.37B | -56M | 382.51M | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -24.84B | -28.34B | -18.46B | -13.72B | -18.4B | -24.44B | -14.15B | -13.83B | -19B | -16.29B | -22.74B | -13.9B | -4.07B | -10.55B | -10.99B | -10.76B | -21.5B | -9.81B | -7.21B | -241M | -2B | -1.47B | -524M | -2.72B | -1.42B | 2.15B | -282.38M | -1.93B | -359.26M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 24.25B | 0 | 80.61B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55.06B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | -1.35B | -1.28B | -297M | -1M | -182M | -19M | 0 | 288M | 187M | -10M | -495M | -3.81B | -199M | -359M | 0 | 0 | -28M | -13M | -16M | 125M | -59.35M | 0 | 2.59B | 0 | -139M | 10.9B | 0 | 0 | 0 |
| Purchase of Investments | -70.5B | -135.36B | 0 | -84.03B | 0 | -120.98B | -111.98B | -80.61B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -76.1B | -48.49B | -49.57B | -53.31B | -65.69B | -59.19B | -47.95B | -38.42B | -46.26B | -48.47B | 0 | 0 | 0 |
| Sale/Maturity of Investments | 61.34B | 108.5B | 0 | 0 | 0 | 96.73B | 0 | 65.33B | 82.11B | 70.72B | 82B | 66.95B | 58.87B | 57.72B | 71.55B | 0 | 137M | 511M | 518M | 52.43B | 63.76B | 116.91B | 93.06B | 74.12B | 91.24B | 39.72B | 33.6B | 0 | 0 |
| Other Investing | -14.32B | -209.83M | -18.16B | 70.32B | -18.22B | -24.42B | 97.83B | -79.45B | -101.3B | -87B | -104.25B | -77.05B | -62.74B | -67.91B | -82.54B | -10.76B | -570M | 38.18B | 41.86B | 509M | 348.7K | -59.19B | -48.22B | -38.42B | -46.26B | 0 | -33.88B | -1.93B | -359.26M |
| Cash from Financing | -3.82B | -2.05B | -4.17B | -5.04B | -2.11B | -2.05B | 663M | -2.08B | -724M | 14M | 3.29B | -2.01B | 21M | 493M | 706M | 655M | 2.24B | 1.18B | 2.07B | -4.58B | -4B | -5.81B | -2.37B | 1.29B | -693M | 1.86B | -959.78M | 693.74M | -28.72M |
| Dividends Paid | -3.37B | -3.3B | -3.16B | -2.97B | -2.79B | -2.5B | -2.34B | -1.4B | -1.79B | -1.78B | -1.59B | -1.43B | -910M | -761M | -733M | -717M | -691M | -1.15B | -1.52B | -1.37B | -1.16B | -940M | -690M | -368M | -285M | -231M | -193M | 0 | 0 |
| Share Repurchases | -1.3B | -2.43B | -3.27B | -1.59B | -1.88B | -612M | -253M | -1.34B | -478M | 0 | 0 | 0 | -800M | 0 | 0 | 0 | 0 | 0 | -403M | -2.25B | -1.63B | -1.24B | -659M | -9.05M | -728.29M | 0 | -206M | -129.17M | 0 |
| Stock Issued | 1B | 1.46B | 144M | 94M | 23M | 51M | 36M | 104M | 59M | 124M | 66M | 37M | 827M | 17M | 0 | 2M | 3M | 2.46B | 2.25B | 130M | 139M | 192.08M | 630M | 2.58M | 10.29M | 2M | 0 | 696.64M | 0 |
| Debt Issuance (Net) | 0 | -1000K | 1000K | -1000K | 1000K | -1000K | 1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | -1000K |
| Other Financing | 1.54B | 3.02B | 859M | 187M | 2B | 9M | -565M | 2.06B | 1.43B | 226M | -189M | -548M | 635M | 525M | 889M | 1.08B | 325M | 1.02B | 2.13B | 2.16B | -4B | -5.6B | -3.31B | 897.16M | 666M | 1.02B | -1.78M | -686.48M | 0 |
| Net Change in Cash | -84.33M | -39.48M | 5.06B | 1.25B | -3.29B | -3.65B | 6.04B | 4.17B | 284M | 860M | -2.76B | -3.44B | 7.55B | 133M | 571M | 958M | -6.99B | 1.47B | 4.92B | 1.54B | 2.07B | 718M | 2.63B | 646M | 147M | 1.28B | 669.9M | 1.68B | -398.88M |
| Exchange Rate Effect | -383.19M | -1.73B | 1.2B | -412M | 585M | -319M | -528M | -466M | 822M | -658M | -347M | 2.1B | 790M | 479M | -221M | 192M | -339M | -1.93B | 2.14B | -1.11B | 23M | -208M | -233M | -577M | 0 | 0 | -1.5M | 0 | 0 |
| Cash at Beginning | 15.14B | 14.94B | 19.88B | 18.64B | 21.93B | 25.58B | 19.55B | 15.38B | 15.1B | 14.24B | 17B | 20.44B | 12.89B | 12.75B | 12.28B | 11.32B | 18.25B | 16.79B | 11.87B | 10.33B | 8.26B | 8.18B | 5.55B | 4.91B | 4.76B | 3.48B | 2.81B | 1.14B | 1.53B |
| Cash at End | 14.56B | 14.9B | 24.94B | 19.88B | 18.64B | 21.93B | 25.58B | 19.55B | 15.38B | 15.1B | 14.24B | 17B | 20.44B | 12.89B | 12.85B | 12.28B | 11.26B | 18.25B | 16.79B | 11.87B | 10.33B | 8.9B | 8.18B | 5.55B | 4.91B | 4.76B | 3.48B | 2.82B | 1.13B |
| Free Cash Flow | 28.96B | 32.08B | 26.49B | 20.42B | 16.63B | 47.41B | 20.05B | 101.15B | 19.19B | 17.79B | 17.04B | 10.33B | 10.81B | 9.71B | 11.08B | 10.87B | 66.62B | 12.02B | 7.92B | 7.47B | 8.05B | 8.2B | 5.75B | 2.65B | 2.26B | -2.73B | 1.91B | 2.91B | -10.91M |
| FCF Growth % | 1.22% | 21.08% | 29.73% | 22.82% | -64.92% | 136.46% | -80.18% | 427.16% | 7.85% | 4.43% | 64.85% | -4.37% | 11.31% | -12.38% | 1.95% | -83.69% | 454.13% | 51.75% | 6.04% | -7.15% | -1.87% | 42.52% | 116.69% | 17.58% | 182.65% | -242.77% | -34.2% | 26767.85% | - |
| FCF Margin % | 36.49% | 60.51% | -363.53% | -290.22% | 68.83% | 79.22% | 26% | 129.98% | 51.49% | 31.41% | 32.96% | 31.49% | 20.36% | 55.52% | 39.46% | 21.74% | 177.09% | 29.97% | 24% | 21% | 23.53% | 25.08% | 21.33% | 16.09% | 13.66% | -16.83% | 13.52% | 20.61% | -0.1% |
| FCF per Share | 16.95 | 18.78 | 14.84 | 11.11 | 8.69 | 24.36 | 10.32 | 51.56 | 9.65 | 8.96 | 8.62 | 5.23 | 5.75 | 5.16 | 5.89 | 5.78 | 35.44 | 6.39 | 4.21 | 3.97 | 4.28 | 4.36 | 3.06 | 1.41 | 1.2 | -1.45 | 1.02 | 1.55 | -0.01 |
Legacy block volatility
As reported in recent financial statements, Manulife's operating cash flow has demonstrated significant quarterly variance, peaking at $9.5 billion in 2025Q3, which suggests that the timing of premium inflows and claims outflows remains highly sensitive to the ongoing restructuring of legacy insurance blocks.
The wide fluctuations in operating cash flow relative to net income, evidenced by an OCF/NI ratio that reached as high as 12.01 in 2025Q1, indicate that statutory earnings are frequently decoupled from actual cash generation. This divergence likely stems from the complex accounting adjustments required under IFRS 17, which may obscure the underlying cash-generative capacity of the core insurance business.
Based on the company's reported figures, Manulife engaged in substantial portfolio turnover in 2026Q1, with $35.1 billion in purchases and $31.7 billion in sales, reflecting an active approach to managing the general account assets against shifting interest rate environments and long-term liability profiles.
The high volume of investment activity suggests that management is aggressively rebalancing the portfolio to optimize yield while maintaining liquidity for potential claims. Investors should monitor whether this high turnover rate leads to realized gains or losses that could introduce further volatility into the company's core earnings profile.
According to the provided data, claims and loss payments have exhibited extreme quarterly swings, ranging from a net inflow of $27.4 billion in 2023Q4 to a massive outflow of $37.4 billion in 2025Q2, highlighting the inherent unpredictability of the company's legacy insurance liabilities.
These erratic payment patterns suggest that the company's cash outflows are heavily influenced by non-recurring events or large-scale reinsurance settlements rather than steady-state mortality trends. Such volatility warrants further investigation into whether these outflows represent a structural risk to liquidity or merely the expected noise associated with de-risking legacy blocks.
As indicated by the financial data, Manulife has maintained consistent dividend payments near $800 million per quarter, while share buybacks have fluctuated significantly, reaching a net outflow of $1.4 billion in 2024Q4, suggesting a flexible but potentially aggressive approach to returning capital to shareholders.
The ability to sustain these capital returns appears contingent on the company's ability to generate consistent cash flow from its insurance operations. If the volatility in claims payments continues to pressure operating cash flow, the current pace of buybacks may prove difficult to maintain without relying on portfolio liquidations.
Quick answers to the most common questions about buying MFC stock.
Manulife Financial Corporation (MFC) generated $32.08B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Manulife Financial Corporation (MFC) generated $32.08B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Manulife Financial Corporation (MFC) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Manulife Financial Corporation (MFC) returned $3.30B to shareholders via cash dividends and spent $2.43B on share repurchases. This shows the company's commitment to returning capital to its equity investors.